Market Access Questions about Humira biosimilars? Widely anticipated biosimilars for Humira are set to enter the US market this year.
Market Access Shifting HCP access calls for new field tactics globally Even before COVID-19 pushed access to an all-time low, access had been declining
Market Access Why we need to support healthcare’s vital acceleration What do I mean by vital acceleration?
Market Access What happened to all the antibiotics? Across the world, there are reports of shortages of common antibiotics.
Market Access Breaking through the forecasting fog - 3 trends that will im... As the legendary investor Warren Buffett once said, forecasts about the future usually tell you more about the forecaster than they do about the future.
Market Access Innovative Medicines Fund and the opportunity for ICSs-indus... In June 2022, NHS England (NHSE) and the National Institute for Health and Care Excellence (NICE) launched the Innovative Medicines Fund (IMF).
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
